Anixa Biosciences, Inc. ANIX
NASDAQ
| 07/31/2026 | 04/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 1.58% | -13.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.40% | -2.54% | |||
| Operating Income | -3.40% | 2.54% | |||
| Income Before Tax | -3.51% | 1.90% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.51% | 1.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -5.00% | 0.00% | |||
| Net Income | -3.58% | 1.91% | |||
| EBIT | -3.40% | 2.54% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -1.74% | 2.98% | |||
| Normalized Basic EPS | -1.72% | 2.92% | |||
| EPS Diluted | -1.74% | 2.98% | |||
| Normalized Diluted EPS | -1.72% | 2.92% | |||
| Average Basic Shares Outstanding | 1.75% | 1.06% | |||
| Average Diluted Shares Outstanding | 1.75% | 1.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||